2,690 results on '"Shedden, A."'
Search Results
152. Supplementary Figure and Table Legends from NF1 Inactivation in Adult Acute Myelogenous Leukemia
153. Supplementary Figures S1-S7 from Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free Quantification
154. Supplementary Figure and Table Legends from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
155. Supplementary table and figure legends from Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia
156. Supplementary Table 1 from A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia
157. Data from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
158. Supplementary Table 1 from Integrated Genomic Profiling, Therapy Response, and Survival in Adult Acute Myelogenous Leukemia
159. CCR Translation for This Article from NF1 Inactivation in Adult Acute Myelogenous Leukemia
160. Supplementary Figure 1-3 from Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia
161. Supplementary Methods from A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia
162. Supplementary Table 3 from A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia
163. Supplementary Figures S1-S5 from A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
164. Supplementary Figure 1 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
165. Supplementary Tables S1-S6 from NF1 Inactivation in Adult Acute Myelogenous Leukemia
166. Data from Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks
167. Supplementary Table 3 from Integrated Genomic Profiling, Therapy Response, and Survival in Adult Acute Myelogenous Leukemia
168. Supplementary Figure 5 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
169. Related CCR Translation from A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
170. Supplementary Figure 2 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
171. Supplementary Data from Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks
172. Supplementary Figure 1 from A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia
173. Supplementary Table 2 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
174. Supplementary Table 2 from Integrated Genomic Profiling, Therapy Response, and Survival in Adult Acute Myelogenous Leukemia
175. Supplementary Legends from Integrated Genomic Profiling, Therapy Response, and Survival in Adult Acute Myelogenous Leukemia
176. Supplementary Figure 4 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
177. Supplementary Figure 3 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
178. Supplementary Table 5 from Integrated Genomic Profiling, Therapy Response, and Survival in Adult Acute Myelogenous Leukemia
179. Supplementary Table 2 from Clonal Evolution, Genomic Drivers, and Effects of Therapy in Chronic Lymphocytic Leukemia
180. Supplementary Figures S1-S2 from NF1 Inactivation in Adult Acute Myelogenous Leukemia
181. Supplementary File 1 from Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression
182. Data from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
183. Supplementary Table 3 from Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression
184. Supplementary Figure Legend 1, Table Legends 1-3 from Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression
185. Supplementary Table 7 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
186. Supplementary Table 10 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
187. Supplementary Table 8 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
188. Supplementary Figure 1 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
189. Supplementary Table 6 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
190. Supplementary Table 3 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
191. sSupplementary Table Legends 1-10, Figure Legend 1 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
192. Supplementary Table 9 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
193. Supplementary Table 4 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
194. Supplementary Table 2 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
195. Supplementary Table 1 from Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression
196. Supplementary Table 2 from Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression
197. Supplementary Table 5 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
198. Supplementary Methods from Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression
199. Is preoperative hypoalbuminaemia or hypoproteinaemia a reliable marker for anastomotic leakage risk in patients undergoing elective colorectal surgery in an Enhanced Recovery after Surgery (ERAS) program?
200. Variability in Sleep Duration and Biomarkers of Cardiovascular Disease across the Menstrual Cycle
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.